Medirom Healthcare Technologies (MRM) Current Deferred Revenue (2019 - 2025)

Medirom Healthcare Technologies' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $145160.9 for Q2 2025.

• In Q2 2025, Current Deferred Revenue rose 139.99% year-over-year to $145160.9; the TTM figure through Jun 2025 stood at $145160.9 (up 139.99% YoY), while the FY2024 annual figure was $351812.3, up 180.01% from the prior year.
• Current Deferred Revenue was $145160.9 for Q2 2025 at Medirom Healthcare Technologies, down from $351812.3 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $916515.7 in Q4 2021 to a low of -$1.1 million in Q2 2021.
• Historically, Current Deferred Revenue has averaged -$163966.8 across 5 years, with a median of -$362988.9 in 2024.
• Biggest YoY gain for Current Deferred Revenue was 180.01% in 2024; the steepest drop was 1742.43% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $916515.7 in 2021, then slumped by 163.82% to -$584923.9 in 2022, then climbed by 24.82% to -$439733.4 in 2023, then soared by 180.01% to $351812.3 in 2024, then plunged by 58.74% to $145160.9 in 2025.
• The last three Current Deferred Revenue figures came in at $145160.9 (Q2 2025), $351812.3 (Q4 2024), and -$362988.9 (Q2 2024), per Business Quant data.